Pfizer will acquire all the outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash, a 78.6% premium to Biohaven’s last closing price., Pfizer will acquire all the outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash, a 78.6% premium to Biohaven’s last closing price., , Read More
AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way